“THE debate over the MRSA ‘crisis’ has been blown out of proportion. I am not saying the ‘superbug’ is not worth talking about, I am pleading for some perspective. Why did it become the focal point for health during the election despite being linked to fewer than 1,000 deaths a year, compared with 117,000 for heart disease? Why has no one, until now, talked about Clostridium difficile . . . and why is the Government not doing more to educate . . . instead of encouraging compensation culture and contributing to hype?”
Let’s all just calm down, says Rob Harteveldt in Nursing Times (June 27)